HELP
Cybin Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · CA
$12.22
+3.82%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.67
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.91
- EPS estimate
- -$0.84
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -31.2%
- Revenue beats (12Q)
- 0
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $48
- PT range
- $16 – $70
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026